Lautem, A.; Boedecker-Lips, S.C.; Schneider, E.; Runkel, S.; Feist, C.; Lang, H.; Weinmann-Menke, J.; Koch, M.
The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients. Pathogens 2023, 12, 910.
https://doi.org/10.3390/pathogens12070910
AMA Style
Lautem A, Boedecker-Lips SC, Schneider E, Runkel S, Feist C, Lang H, Weinmann-Menke J, Koch M.
The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients. Pathogens. 2023; 12(7):910.
https://doi.org/10.3390/pathogens12070910
Chicago/Turabian Style
Lautem, Anja, Simone Cosima Boedecker-Lips, Elisa Schneider, Stefan Runkel, Christina Feist, Hauke Lang, Julia Weinmann-Menke, and Martina Koch.
2023. "The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients" Pathogens 12, no. 7: 910.
https://doi.org/10.3390/pathogens12070910
APA Style
Lautem, A., Boedecker-Lips, S. C., Schneider, E., Runkel, S., Feist, C., Lang, H., Weinmann-Menke, J., & Koch, M.
(2023). The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients. Pathogens, 12(7), 910.
https://doi.org/10.3390/pathogens12070910